Poke and a Placebo

Sponsor
University of Minnesota (Other)
Overall Status
Recruiting
CT.gov ID
NCT04497220
Collaborator
(none)
30
1
2
16.7
1.8

Study Details

Study Description

Brief Summary

To discover if a positive description of the procedure for an epidural can reduce the overall pain score associated with the procedure.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Negative Connotation Langauge
  • Behavioral: Positive Connotation Language
N/A

Detailed Description

The study intervention consists of two separate scripts read to the patient by the anesthesiologist performing their labor epidural. One script will contain the wording "Poke and a burn" prior to subcutaneous local anesthetic administration for the epidural placement and one will contain "this is numbing medication, which will make the rest of the procedure go easier". There will be no difference in the epidural placement, medications, or the rest of the script.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Will Negative Phrasing Create a Nocebo Effect During Epidural Placement When Compared to Positive Phrasing? A Randomized Controlled Trial
Actual Study Start Date :
Jul 12, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Nocebo Group

Participants in this group will receive the control treatment

Behavioral: Negative Connotation Langauge
The study intervention consists of two separate scripts read to the patient by the anesthesiologist performing their labor epidural. The control script includes language containing the wording "Poke and a burn" said prior to numbing medication for the epidural procedure. There will be no difference in the epidural placement, medications, or the rest of the script.

Experimental: Positive Connotation Group

Participants in this group will receive the experimental treatment.

Behavioral: Positive Connotation Language
The study intervention consists of two separate scripts read to the patient by the anesthesiologist performing their labor epidural. The experimental script includes language containing the wording "this is numbing medication, which will make the rest of the procedure go easier" said prior to numbing medication for the epidural procedure. There will be no difference in the epidural placement, medications, or the rest of the script.

Outcome Measures

Primary Outcome Measures

  1. Max pain score during the epidural procedure [1 hour]

    Maximum pain score will be measured using a single 11-point Numeric Rating Scale 0-10, where 0 is no pain and 10 is maximum imaginable pain.

Secondary Outcome Measures

  1. Overall satisfaction during the epidural procedure [1 hour]

    Overall satisfaction during the epidural procedure will be measured used a 5-point likert scale: 5=very satisfied, 4=satisfied, 3=neither satisfied or dissatisfied, 2=dissatisfied, 1=very dissatisfied.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • pregnancy

  • requesting an epidural for the first time

Exclusion Criteria:
  • previous epidural (either for labor or for surgery)

  • BMI greater than 40 kg/m^2

  • previous lumbar spine surgery

  • inability to speak English

  • a history of chronic pain or are on chronic opioids

  • a history of opioid drug abuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Minnesota Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • University of Minnesota

Investigators

  • Principal Investigator: Aaron Berg, MD, University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Minnesota
ClinicalTrials.gov Identifier:
NCT04497220
Other Study ID Numbers:
  • ANES-2020-29006
First Posted:
Aug 4, 2020
Last Update Posted:
Mar 7, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Minnesota

Study Results

No Results Posted as of Mar 7, 2022